mortality/aging
• in TNF-treated mice following administration of an antibody that neutralizes the knock-in protein
|
neoplasm
• of subcutaneous B16BL6 tumor cells in mice treated with TNF and IFN-gamma without systemic toxicity following administration of an antibody that neutralizes the knock-in protein
|